These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 1436658
1. In vitro quantitative autoradiography of [125I]alpha-bungarotoxin binding at the motor end-plates of experimental autoimmune myasthenia gravis. Motomura M, Niwa M, Kataoka Y, Ootsuru I, Yoshimura T, Tsujihata M, Nagataki S. Neurosci Lett; 1992 Aug 31; 143(1-2):139-42. PubMed ID: 1436658 [Abstract] [Full Text] [Related]
2. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. Lindstrom JM, Einarson BL, Lennon VA, Seybold ME. J Exp Med; 1976 Sep 01; 144(3):726-38. PubMed ID: 182896 [Abstract] [Full Text] [Related]
3. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis. Fumagalli G, Engel AG, Lindstrom J. J Neuropathol Exp Neurol; 1982 Nov 01; 41(6):567-79. PubMed ID: 6982313 [Abstract] [Full Text] [Related]
8. The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Engel AG, Tsujihata M, Lindstrom JM, Lennon VA. Ann N Y Acad Sci; 1976 Nov 01; 274():60-79. PubMed ID: 1066997 [Abstract] [Full Text] [Related]
9. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin. Elias SB, Appel SH. Ann Neurol; 1978 Sep 01; 4(3):250-2. PubMed ID: 718136 [Abstract] [Full Text] [Related]
10. Search for nicotinic acetylcholine receptors on human leukocytes: absence of alpha-bungarotoxin binding in studies of healthy individuals and myasthenia gravis patients. Kaufman RL, Oger J. J Neuroimmunol; 1989 Jun 01; 23(1):83-7. PubMed ID: 2723042 [Abstract] [Full Text] [Related]
11. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. Lindstrom JM, Engel AG, Seybold ME, Lennon VA, Lambert EH. J Exp Med; 1976 Sep 01; 144(3):739-53. PubMed ID: 182897 [Abstract] [Full Text] [Related]
16. Experimental autoimmune myasthenia gravis: can pretreatment with 125I-labeled receptor prevent functional damage at the neuromuscular junction? Sterz RK, Biro G, Rajki K, Filipp G, Peper K. J Immunol; 1985 Feb 01; 134(2):841-6. PubMed ID: 2578165 [Abstract] [Full Text] [Related]
17. Morphologic and immunologic studies in experimental autoimmune myasthenia gravis and myasthenia gravis. Trotter JL, Ringel SP, Cook JD, Engel WK, Eldefrawi ME, McFarlin DE. Neurology; 1977 Dec 01; 27(12):1120-4. PubMed ID: 73154 [Abstract] [Full Text] [Related]
18. Acetylcholine release in myasthenia gravis: regulation at single end-plate level. Plomp JJ, Van Kempen GT, De Baets MB, Graus YM, Kuks JB, Molenaar PC. Ann Neurol; 1995 May 01; 37(5):627-36. PubMed ID: 7755358 [Abstract] [Full Text] [Related]
19. Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis. Verschuuren JJ, Graus YM, Theunissen RO, Yamamoto T, Vincent A, van Breda Vriesman PJ, De Baets MH. J Neuroimmunol; 1992 Feb 01; 36(2-3):117-25. PubMed ID: 1732277 [Abstract] [Full Text] [Related]